NASDAQ: MRSN       Mersana Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
4.24   +0.08 (1.92%)  3.81 - 4.49  505,300


Avg Volume (4 weeks):315,325
4 Weeks Range:1.69 - 4.49
4 Weeks Price Volatility (%):
52 Weeks Range:1.32 - 7.65
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company. It is focused on developing antibody drug conjugates, or ADCs, that offer a clinically meaningful benefit for cancer patients with significant unmet need. The company's most advanced platform, Dolaflexin, has been used to generate a pipeline of proprietary ADC product candidates to address patient populations that are not currently amenable to treatment with traditional ADC-based therapies. Its lead product candidate, XMT-1522, is a HER2-targeted ADC is in a Phase 1 dose escalation study in primarily breast cancer patients as well as non-small cell lung cancer (NSCLC) and gastric cancer.

  Be the first to like this.


4706  3347  638  230 

Top 10 Active Counters
 CELG 108.24+0.11 
 GDX 26.97-0.65 
 CHK 0.76+0.041 
 EEM 43.07+0.25 
 BAC 33.67+0.58 
 GE 11.10+0.31 
 SPY 314.87+2.85 
 XOP 21.23+0.74 
 VIAB 24.22+0.75 
 ONTX 0.35+0.058 
Partners & Brokers